Skip to content

CNSP CNS PHARMACEUTICALS INC

Follow

COM (common), issuer CIK 1729427

8 managers (8 13F filers) reported a position in CNSP shares at 2025-09-30, 24,616 shares in all. 8 filers opened a position and 1 filer sold out during the quarter.

Managers
8
13F filers
8
New
8
Added
0
Reduced
0
Sold out
1
Shares held by filers
24,616

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2025

Filers in the available 13F reports with a share position at 2025-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
DRW Securities, LLC14,050$126K0.01%new13F-HRTimeline
UBS Group AGin group UBS Group AG10,520$94.7K<0.01%new13F-HRTimelineGroup
MORGAN STANLEYin group MORGAN STANLEY28$252<0.01%new13F-HR/ATimelineGroup
BARRETT & COMPANY, INC.8$72<0.01%new13F-HRTimeline
BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/4$36<0.01%new13F-HR/ATimelineGroup
MAI Capital Management3$27<0.01%new13F-HRTimeline
CITIGROUP INCin group CITIGROUP INC2$18<0.01%new13F-HRTimelineGroup
DANSKE BANK A/S1$9<0.01%new13F-HR/ATimeline